{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:37:21Z","timestamp":1783075041782,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06810-x","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:43:40Z","timestamp":1768985020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers"],"prefix":"10.1007","volume":"105","author":[{"given":"Junichi","family":"Mukae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuka","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikage","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"6810_CR1","volume-title":"World health organization classification of tumours. Pathology and genetics of tumours of Haematopoietic and lymphoid tissues","year":"2001","unstructured":"Jaffe ES, Harris N, Stein H, Vardiman JW (eds) (2001) World health organization classification of tumours. Pathology and genetics of tumours of Haematopoietic and lymphoid tissues, 3rd edn. IARC, Lyon","edition":"3"},{"issue":"18","key":"6810_CR2","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","volume":"132","author":"Y Natkunam","year":"2018","unstructured":"Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D (2018) Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood 132(18):1871\u20131878. https:\/\/doi.org\/10.1182\/blood-2018-04-842559","journal-title":"Blood"},{"issue":"2","key":"6810_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/ajcp\/aqw200","volume":"147","author":"Y Natkunam","year":"2017","unstructured":"Natkunam Y, Gratzinger D, de Jong D, Chadburn A, Goodlad JR, Chan JK, Said J, Jaffe ES (2017) Immunodeficiency and dysregulation: report of the 2015 workshop of the society for Hematopathology\/European association for haematopathology. Am J Clin Pathol 147(2):124\u2013128. https:\/\/doi.org\/10.1093\/ajcp\/aqw200","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"6810_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"2","key":"6810_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3960\/jslrt.19014","volume":"59","author":"S Momose","year":"2019","unstructured":"Momose S, Tamaru JI (2019) Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting. J Clin Exp Hematop 59(2):48\u201355. https:\/\/doi.org\/10.3960\/jslrt.19014","journal-title":"J Clin Exp Hematop"},{"key":"6810_CR6","volume-title":"World health organization classification of tumours of Haematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) World health organization classification of tumours of Haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon","edition":"4"},{"issue":"7","key":"6810_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/cancers16071298","volume":"16","author":"K Ohsawa","year":"2024","unstructured":"Ohsawa K, Momose S, Nishikori A, Nishimura MF, Gion Y, Sawada K, Higashi M, Tokuhira M, Tamaru JI, Sato Y (2024) Copy number analysis of 9p24.1 in classic hodgkin lymphoma arising in immune deficiency\/dysregulation. Cancers 16(7):1298. https:\/\/doi.org\/10.3390\/cancers16071298","journal-title":"Cancers"},{"key":"6810_CR8","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.blre.2023.101167","volume":"64","author":"A Carbone","year":"2024","unstructured":"Carbone A, Chadburn A, Gloghini A, Vaccher E, Bower M (2024) Immune deficiency\/dysregulation -associated lymphoproliferative disorders. Revised classification and management. Blood Rev 64:101167. https:\/\/doi.org\/10.1016\/j.blre.2023.101167","journal-title":"Blood Rev"},{"key":"6810_CR9","volume-title":"World health organization classification of tumours of Haematopoietic and lymphoid tissues","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) (2017) World health organization classification of tumours of Haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon","edition":"4"},{"issue":"5","key":"6810_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.21873\/invivo.11642","volume":"33","author":"K Yoshifuji","year":"2019","unstructured":"Yoshifuji K, Umezawa Y, Ichikawa A, Watanabe K, Miura O, Yamamoto M (2019) Methotrexate-associated classical hodgkin lymphoma shows distinct clinicopathological features but comparable clinical outcomes with sporadic cases. Vivo 33(5):1599\u20131604. https:\/\/doi.org\/10.21873\/invivo.11642","journal-title":"Vivo"},{"issue":"1","key":"6810_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.51.1","volume":"51","author":"H Yamaguchi","year":"2011","unstructured":"Yamaguchi H, Hirakawa T, Inokuchi K (2011) Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma. J Clin Exp Hematop 51(1):1\u20135. https:\/\/doi.org\/10.3960\/jslrt.51.1","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"6810_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transpl"},{"issue":"18","key":"6810_CR13","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1200\/JCO.2004.02.171","volume":"22","author":"M Picardi","year":"2004","unstructured":"Picardi M, Gennarelli N, Ciancia R, De Renzo A, Gargiulo G, Ciancia G, Sparano L, Zeppa P, Martinelli V, Pettinato G, Lobello R, Pane F, Rotoli B (2004) Randomized comparison of power doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. J Clin Oncol 22(18):3733\u20133740. https:\/\/doi.org\/10.1200\/JCO.2004.02.171","journal-title":"J Clin Oncol"},{"issue":"5","key":"6810_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/hon.3204","volume":"41","author":"M Picardi","year":"2023","unstructured":"Picardi M, Giordano C, Vigliar E, Zeppa P, Cozzolino I, Pugliese N, Della Pepa R, Esposito M, Abagnale DP, Ciriello M, Muccioli-Casadei G, Troncone G, Russo D, Mascolo M, Varricchio S, Accarino R, Persico M, Pane F (2023) Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study. Hematol Oncol 41(5):817\u2013827. https:\/\/doi.org\/10.1002\/hon.3204","journal-title":"Hematol Oncol"},{"issue":"5","key":"6810_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/bjh.18348","volume":"198","author":"M Picardi","year":"2022","unstructured":"Picardi M, Giordano C, Pugliese N, Esposito M, Fatigati M, Muriano F, Rascato MG, Della Pepa R, D\u2019Ambrosio A, Vigliar E, Troncone G, Russo D, Mascolo M, Esposito G, Prastaro M, Esposito R, Tocchetti CG, Fonti R, Mainolfi C, Del Vecchio S, Pane F (2022) Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical hodgkin lymphoma: preliminary results of a single-centre phase II study. Br J Haematol 198(5):847\u2013860. https:\/\/doi.org\/10.1111\/bjh.18348","journal-title":"Br J Haematol"},{"issue":"4","key":"6810_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa1708984","volume":"378","author":"JM Connors","year":"2018","unstructured":"Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Ill\u00e9s \u00c1, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J, ECHELON-1 Study Group (2018) Brentuximab Vedotin with chemotherapy for stage III or IV hodgkin\u2019s lymphoma. N Engl J Med 378(4):331\u2013344. https:\/\/doi.org\/10.1056\/NEJMoa1708984","journal-title":"N Engl J Med"},{"issue":"6","key":"6810_CR17","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/hon.70003","volume":"42","author":"M Picardi","year":"2024","unstructured":"Picardi M, Vincenzi A, Giordano C, Fazio L, Pugliese N, Scarpa A, Vigliar E, Troncone G, Russo D, Mascolo M, Esposito G, Prastaro M, Santoro C, Esposito R, Tocchetti CG, Mainolfi C, Fonti R, Vecchio SD, Carchia M, Quagliano C, Salemme A, Damiano V, Bianco R, Trastulli F, Ronconi F, Annunziata M, Pane F (2024) Liposomal doxorubicin, vinblastine and Dacarbazine plus consolidation radiotherapy of residual nodal masses for frontline treatment in older adults with advanced-stage classic hodgkin lymphoma: improved outcome in a multi-center real-life study. Hematol Oncol 42(6):e70003. https:\/\/doi.org\/10.1002\/hon.70003","journal-title":"Hematol Oncol"},{"issue":"1","key":"6810_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/16078454.2019.1598678","volume":"24","author":"M Yang","year":"2019","unstructured":"Yang M, Ping L, Liu W, Xie Y, Aliya, Liu Y, Nuersulitan R, Zhu J, Wu M, Song Y (2019) Clinical characteristics and prognostic factors of primary extranodal classical hodgkin lymphoma: a retrospective study. Hematology 24(1):413\u2013419. https:\/\/doi.org\/10.1080\/16078454.2019.1598678","journal-title":"Hematology"},{"issue":"24","key":"6810_CR19","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.1158\/1078-0432.CCR-13-1879","volume":"19","author":"PR Marri","year":"2013","unstructured":"Marri PR, Hodge LS, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Cerhan JR, Novak AJ, Ansell SM (2013) Prognostic significance of pretreatment serum cytokines in classical hodgkin lymphoma. Clin Cancer Res 19(24):6812\u20136819. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1879","journal-title":"Clin Cancer Res"},{"issue":"9","key":"6810_CR20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00277-019-03738-3","volume":"98","author":"K Umino","year":"2019","unstructured":"Umino K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y (2019) Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical hodgkin lymphoma treated with ABVD with or without radiotherapy. Ann Hematol 98(9):2121\u20132129. https:\/\/doi.org\/10.1007\/s00277-019-03738-3","journal-title":"Ann Hematol"},{"issue":"3","key":"6810_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12(3):180\u2013190. https:\/\/doi.org\/10.1038\/nri3156","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"6810_CR22","first-page":"220","volume":"78","author":"WA Dik","year":"2020","unstructured":"Dik WA, Heron M (2020) Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med 78(5):220\u2013231","journal-title":"Neth J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06810-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:41Z","timestamp":1771398221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6810"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06810-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of the Institute of Science Tokyo Hospital (approval number: M2017-086). As this was a retrospective study, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NU: Kyowa Kirin: Honoraria, YU: Takeda: Honoraria, KY: Kyowa Kirin: Honoraria, TN: Takeda: Honoraria, SY: Kyowa Kirin: Honoraria, HK: Takeda: Honoraria, TM: Takeda: Honoraria; Kyowa Kirin: Research Funding, MY: Takeda: Honoraria; Kyowa Kirin: Honoraria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}